Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin in Dyslipidemia with Statin-Induced Myalgia
NCT00125125Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2005
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in dyslipidemia comparing Fluvastatin with Placebo (2 arms). Primary endpoint: Change from baseline in low density lipoprotein cholesterol at 12 weeks. Started May 2005; status: completed.
02
Drugs
fluvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00125125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125125.